Regeneron Releases New Linvoseltamab Analysis As It Inches Toward ASH, Regulatory Filing

 
• By Alaric DeArment
Regeneron announced an analysis from the Phase I/II LINKER-MM1 trial of linvoseltamab • Source: Shutterstock

More from Immuno-oncology

More from Anticancer